The REACH registration process: A case study of metallic aluminium, aluminium oxide and aluminium hydroxide.


Journal

Neurotoxicology
ISSN: 1872-9711
Titre abrégé: Neurotoxicology
Pays: Netherlands
ID NLM: 7905589

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 9 12 2020
medline: 27 11 2021
entrez: 8 12 2020
Statut: ppublish

Résumé

The European Union's REACH Regulation requires determination of potential health and environmental effects of chemicals in commerce. The present case study examines the application of REACH guidance for health hazard assessments of three high production volume (HPV) aluminium (Al) substances: metallic aluminium, aluminium oxide, and aluminium hydroxide. Among the potential adverse health consequences of aluminium exposure, neurotoxicity is one of the most sensitive targets of Al toxicity and the most critical endpoint. This case study illustrates integration of data from multiple lines of evidence into REACH weight of evidence evaluations. This case study then explains how those results support regulatory decisions on classification and labelling. Challenges in the REACH appraisal of Al compounds include speciation, solubility and bioavailability, application of assessment factors, read-across rationale and differences with existing regulatory standards. Lessons learned from the present case study relate to identification and evaluation of toxicologic and epidemiologic data; assessing data relevance and reliability; development of derived no-effect levels (DNELs); addressing data gaps and preparation of chemical safety reports.

Identifiants

pubmed: 33290785
pii: S0161-813X(20)30211-4
doi: 10.1016/j.neuro.2020.12.004
pii:
doi:

Substances chimiques

Aluminum Hydroxide 5QB0T2IUN0
Aluminum CPD4NFA903
Aluminum Oxide LMI26O6933

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

166-178

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Calvin C Willhite (CC)

Risk Sciences International, Ottawa, Canada. Electronic address: calvinwillhite@hotmail.com.

Nataliya A Karyakina (NA)

Risk Sciences International, Ottawa, Canada; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Canada. Electronic address: nkaryakina@risksciences.com.

Eirik Nordheim (E)

European Aluminium, Brussels, Belgium.

Ian Arnold (I)

International Aluminium Institute, London, United Kingdom; Occupational Health Program, Faculty of Medicine, McGill University, Montreal, QC, Canada.

Vic Armstrong (V)

Risk Sciences International, Ottawa, Canada.

Franco Momoli (F)

Risk Sciences International, Ottawa, Canada; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Canada; Faculty of Medicine, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Natalia S Shilnikova (NS)

Risk Sciences International, Ottawa, Canada; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Canada.

Nagarajkumar Yenugadhati (N)

Risk Sciences International, Ottawa, Canada; Department of Epidemiology and Biostatistics, College of Public Health and Health Informatics, King Saud bin Abdul-Aziz University for Health Sciences, Riyadh, Saudi Arabia.

Daniel Krewski (D)

Risk Sciences International, Ottawa, Canada; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Canada; Faculty of Medicine, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH